China Agency - Business Introduction
The company
obtained the MAH drug manufacturing license in October 2020, possess a quality
management team, and established quality management system in accordance with
the Chinese Drug Administration Law, including QA, QC, materials, production,
sales and other links. It can accept the entrustment of overseas enterprises to
act as agent.
Current varieties:
Levofloxacin hydrochloride eye drops
Moxifloxacin hydrochloride eye drops
Citicoline Injection
Calcium acetate tablet
Nimodipine API